• Home
  • News
  • Analysis
  •  
    Regions
    • Australasia
    • Southeast Asia
    • Greater China
    • North Asia
    • South Asia
    • North America
    • Europe
    • Central Asia
    • MENA
  •  
    Funds
    • LPs
    • Buyout
    • Growth
    • Venture
    • Renminbi
    • Secondary
    • Credit/Special Situations
    • Infrastructure
    • Real Estate
  •  
    Investments
    • Buyout
    • Growth
    • Early stage
    • PIPE
    • Credit
  •  
    Exits
    • IPO
    • Open market
    • Trade sale
    • Buyback
  •  
    Sectors
    • Consumer
    • Financials
    • Healthcare
    • Industrials
    • Infrastructure
    • Media
    • Technology
    • Real Estate
  • Events
  • Chinese edition
  • Data & Research
  • Weekly Digest
  • Newsletters
  • Sign in
  • Events
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)870 240 8859

      Email: customerservices@incisivemedia.com

      • Sign in
     
      • Saved articles
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • RSS
    • Twitter
    • LinkedIn
    • Newsletters
  • Free Trial
  • Subscribe
  • Weekly Digest
  • Chinese edition
  • Data & Research
    • Latest Data & Research
      2023-china-216x305
      Regional Reports

      The reports review the year's local private equity and venture capital activity and are filled with up-to-date data and intelligence on fundraising, investments, exits and M&A. The regional reports also feature information on key companies.

      Read more
      2016-pevc-cover
      Industry Review

      Asian Private Equity and Venture Capital Review provides an independent overview of the private equity, venture capital and M&A activities in the Asia region. It delivers insights on investments made, capital raised, sector specific figures and more.

      Read more
      AVCJ Database

      AVCJ Database is the ultimate link between Asian dealmakers and those who provide advisory, financial, legal and technological services to the private equity, venture capital and M&A industries. It is packed with facts and figures on more than 153,000 companies and almost 117,000 transactions.

      Read more
AVCJ
AVCJ
  • Home
  • News
  • Analysis
  • Regions
  • Funds
  • Investments
  • Exits
  • Sectors
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)870 240 8859

    Email: customerservices@incisivemedia.com

    • Sign in
 
    • Saved articles
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 

China

cainiao
Alibaba invests $3.3b in logistics affiliate Cainiao

Alibaba Group has enlarged a controlling stake in its PE-backed shipping affiliate Cainiao Smart Logistics Network with a $3.3 billion investment.

  • Greater China
  • 11 November 2019
China's Qingke trades up on debut after smaller than expected IPO

Q&K International Group, operator of China-based long-term apartment rentals platform Qingke, posted a marginal gain on its US trading debut after raising $45.9 million in an IPO priced at the bottom end of the indicative range.

  • Greater China
  • 08 November 2019
baijiu
Singapore’s Tembusu seeks $287m for China liquor fund

Singapore private equity firm Tembusu Partners has received a strategic commitment of up to RMB670 million ($96 million) for a RMB2 billion fund targeting the liquor industry in China’s Guizhou province.

  • Southeast Asia
  • 08 November 2019
astrazeneca-cicc-healthcare
CICC, AstraZeneca launch $1b China healthcare fund

China International Capital Corporation (CICC) and global pharmaceutical giant AstraZeneca are looking to raise $1 billion for a fund that will back Chinese healthcare companies as well as international players looking to enter the country.

  • Greater China
  • 08 November 2019
PE & QSR: Dining disrupted

With ubiquitous delivery services, ordering apps that learn user preferences, and intelligent inventory management, technology is changing China’s restaurant industry. Operators are in a race to stay relevant

  • Greater China
  • 08 November 2019
SoftBank founder admits to lapses on WeWork

SoftBank founder Masayoshi Son admitted to a lapse in judgment on WeWork while disclosing that SoftBank Vision Fund and SoftBank Group have written down their positions in the beleaguered co-working space provider by a combined $7.7 billion.

  • North Asia
  • 07 November 2019
Eastern Bell closes first US dollar fund at $365m

China’s Eastern Bell Capital has closed its first US dollar-denominated fund at $365 million, exceeding the target of $350 million.

  • Greater China
  • 07 November 2019
Investcorp backs $500m Asia food fund

Investcorp has teamed up with China Resources and Fung Investments, the private investment arm of the founding family of Hong Kong consumer goods and supply chain conglomerate Fung Group, to raise a $500 million Asia food fund.

  • Greater China
  • 07 November 2019
dreamstime-m-71844914-s
PE & QSR: Ambition on a bun

Many private equity investors think they can make a fast buck from fast dining, but rolling out a Western-style brand in Asia requires discipline on valuation and competence in execution

  • Greater China
  • 06 November 2019
business-handshake-agreement
China Everbright, Investcorp deepen China tech partnership

China Everbright and Investcorp have agreed to combine their respective China technology-focused investment teams and co-manage a recently launched fund targeting the sector.

  • Greater China
  • 06 November 2019
VCs set for exit as Alibaba buys IDsManager

Alibaba Cloud, the cloud computing unit of Alibaba Group, has agreed to acquire IDsManager, a Chinese cloud-based ID management platform backed by Qiming Venture Partners and Fortune Capital.

  • Greater China
  • 06 November 2019
Chinese antibody drug developer raises $150m

Akeso Biopharma, a Chinese biotech company specializing in antibody drugs, has raised a $150 million Series D round led by Loyal Valley Capital and Sino Biopharm.

  • Greater China
  • 06 November 2019
ehang-drone-passenger
Chinese drone maker EHang targets US listing

Chinese drone manufacturer EHang has filed for a US IPO, potentially delivering a liquidity event for investors including GGV Capital and ZhenFund.

  • Greater China
  • 05 November 2019
Chinese fresh produce retailer raises $14m

Maison Capital has invested RMB100 million ($14 million) in Sungiven Foods, a Chinese fresh produce retailer looking to replicate the model of US-based Trader Joe's.

  • Greater China
  • 05 November 2019
esr-ipo
ESR raises $1.6b in up-sized HK IPO, gains on debut

Pan-Asian logistics and fund management platform ESR gained 5.4% on its first day of trading in Hong Kong after completing Asia's second-largest IPO of the year.

  • Greater China
  • 04 November 2019
fangdd-ipo
China property marketplace trades flat after $78m IPO

Chinese online real estate marketplace Fangdd Network raised $78 million in its US IPO, having reduced the size of the offering, and traded flat on its first day on NASDAQ.

  • Greater China
  • 04 November 2019
Fund focus: J.P. Gan bucks VC fundraising trend

Having spent 12 years at Qiming Venture Partners, J.P. Gan has raised $352 million for his debut fund at Ince Capital Partners. More early-stage consumer internet deals will follow

  • Greater China
  • 01 November 2019
China car finance player targets US IPO

Meili Auto, a Chinese car financing platform, has filed for US IPO. Its backers include Gaorong Capital, China International Capital Corporation (CICC), and Lingfeng Capital.

  • Greater China
  • 01 November 2019
China's I-Mab Biopharma pursues US IPO

I-Mab Biopharma, the product of a CBC Group-engineered merger of two Chinese drug developers, has announced plans for a NASDAQ IPO.

  • Greater China
  • 01 November 2019
China media platform Lizhi pursues US listing

Lizhi, a Guangzhou-based audio streaming and social networking platform backed by Matrix Partners China and Morningside Venture Capital, has filed for a US IPO.

  • Greater China
  • 31 October 2019
Chinese auto parts platform Casstime raises $80m

Sequoia Capital China and Source Code Capital have co-led a $80 million funding round – described as the first tranche of a Series C – for Chinese aftermarket car parts supplier Casstime.

  • Greater China
  • 31 October 2019
China's Danke raises $190m, files for US IPO

China-based long-term apartment rental platform Danke has filed for a US IPO. It comes a fortnight after the company raised $190 million in Series D funding from CMC Capital Partners and Primavera Capital Group.

  • Greater China
  • 31 October 2019
PE-backed bitcoin mining company files for US IPO

Canaan, which claims to be China’s leading manufacturer of bitcoin mining equipment has filed for a US IPO. This follows failed attempts to list in Hong Kong and complete a reverse merger in Shenzhen.

  • Greater China
  • 30 October 2019
KKR plans Asia tech fund

KKR plans to raise a growth-stage technology fund focused on Asia, expanding a strategy that is already operational in North America, Europe, and Israel.

  • Fundraising
  • 30 October 2019
79 80 81
  • About AVCJ
  • Advertise
  • Contacts
  • About ION Analytics
  • Terms of use
  • Privacy policy
  • Group disclaimer
  • RSS
  • Twitter
  • LinkedIn
  • Newsletters

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013